Survival in Patients with Paramedic-Identified ST-Segment Elevation Myocardial Infarction

被引:4
|
作者
Doan, Tan N. [1 ,2 ,3 ]
Wilson, Kirsten [1 ]
Schultz, Brendan V. [1 ]
Rogers, Brett [1 ]
Vollbon, William [4 ]
Prior, Marcus [4 ]
Rashford, Stephen [1 ,5 ]
Bosley, Emma [1 ,6 ]
机构
[1] Queensland Govt Dept Hlth, Queensland Ambulance Serv, Brisbane, Qld, Australia
[2] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne, Vic, Australia
[3] James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld, Australia
[4] Queensland Govt Dept Hlth, Statewide Cardiac Clin Informat Unit, Brisbane, Qld, Australia
[5] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia
[6] Queensland Univ Technol, Sch Clin Sci, Brisbane, Qld, Australia
关键词
CORONARY-ARTERY-DISEASE; OBESITY PARADOX; PREHOSPITAL THROMBOLYSIS; MORTALITY; SEVERITY; TRENDS; DELAY; TIME;
D O I
10.1080/10903127.2020.1809753
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background Field identification and treatment of ST-segment elevation myocardial infarction (STEMI) by paramedics is an important component of care for these patients. There is a paucity of studies in the setting of paramedic-identified STEMI. This study investigated mortality and factors associated with mortality in a large state-wide prehospital STEMI sample.Methods:Included were adult STEMI patients identified and treated with reperfusion therapy by paramedics in the field between January 2016 and December 2018 in Queensland, Australia. 30-day and one-year all-cause mortality was compared between two prehospital reperfusion pathways: prehospital fibrinolysis versus direct referral to a hospital for primary percutaneous coronary intervention (direct percutaneous coronary intervention [PCI] referral). For prehospital fibrinolysis patients, factors associated with failed fibrinolysis were investigated. For direct PCI referral patients, factors associated with mortality were examined.Results:The 30-day mortality was 2.2% for prehospital fibrinolysis group and 1.8% for direct PCI referral group (p = 0.661). One-year mortality for the two groups was 2.7% and 3.2%, respectively (p = 0.732). Failed prehospital fibrinolysis was observed in 20.1% of patients receiving this therapy, with male gender and history of heart failure being predictors. For direct PCI referral group, low left ventricular ejection fraction (LVEF) on admission and cardiogenic shock prior to PCI were predictors of both 30-day and one-year mortality. Aboriginal and Torres Strait Islander status, and impaired kidney function on admission, were associated with one-year but not 30-day mortality. Being overweight was associated with lower 30-day mortality.Conclusions:Mortality in STEMI patients identified and treated by paramedics was low, and the prehospital fibrinolysis treatment pathway was effective with a mortality rate comparable to that of patients undergoing primary PCI.Key words:prehospital; Queensland; cardiac reperfusion; STEMI
引用
收藏
页码:487 / 495
页数:9
相关论文
共 50 条
  • [31] Impact of Emergency Medical System Transportation in ST-segment Elevation Myocardial Infarction: A Nationwide Retrospective Study
    Pereira, Julio Gil
    Abreu, Luis
    Antunes, Hugo
    Goncalves, Maria Luisa
    Marmelo, Bruno
    Moreira, Davide
    Nunes, Luis
    Santos, Jorge Oliveira
    ACTA MEDICA PORTUGUESA, 2020, 33 (06): : 390 - 400
  • [32] PREHOSPITAL ADMINISTRATION OF TENECTEPLASE FOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN A RURAL EMS SYSTEM
    Crowder, Joseph S.
    Hubble, Michael W.
    Gandhi, Sanjay
    McGinnis, Henderson
    Zelman, Stacie
    Bozeman, William
    Winslow, James
    PREHOSPITAL EMERGENCY CARE, 2011, 15 (04) : 499 - 505
  • [33] Use of the Thrombolysis in Myocardial Infarction Risk Index for Elderly Patients With ST-Segment Elevation Myocardial Infarction
    Fu, Bingqi
    Wei, Xuebiao
    Wang, Qi
    Yang, Zhiwen
    Chen, Jiyan
    Yu, Danqing
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [34] Temporal Trends in the Clinical Acuity of Patients with ST-Segment Elevation Myocardial Infarction
    Krishnan, Udhay
    Brejt, Josef A.
    Schulman-Marcus, Joshua
    Swaminathan, Rajesh V.
    Feldman, Dmitriy N.
    Goyal, Parag
    Wong, S. Chiu
    Minutello, Robert M.
    Bergman, Geoffrey
    Singh, Harsimran
    Kim, Luke K.
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (01) : 100.e9 - 100.e20
  • [35] Acute myocardial infarction in patients with ST-segment elevation myocardial infarction. ESC guidelines 2017
    Thiele, H.
    Desch, S.
    de Waha, S.
    HERZ, 2017, 42 (08) : 728 - 738
  • [36] Determinants of Angiographic Thrombus Burden in Patients With ST-Segment Elevation Myocardial Infarction
    Tanboga, Ibrahim Halil
    Topcu, Selim
    Aksakal, Enbiya
    Kalkan, Kamuran
    Sevimli, Serdar
    Acikel, Mahmut
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2014, 20 (07) : 716 - 722
  • [37] Prognostic impact of cardiohepatic syndrome in patients with ST-segment elevation myocardial infarction
    Sungur, Mustafa A.
    Sungur, Aylin
    Karagoz, Ali
    Can, Fatma
    Yilmaz, Mehmet F.
    Zeren, Gonul
    Avci, Ilhan I.
    Yumurtas, Ahmet C.
    Tanboga, Ibrahim H.
    Karabay, Can Y.
    BIOMARKERS IN MEDICINE, 2023, 17 (02) : 111 - 121
  • [38] The Systemic Inflammatory Response Syndrome in Patients With ST-Segment Elevation Myocardial Infarction
    van Diepen, Sean
    Vavalle, John P.
    Newby, L. Kristin
    Clare, Robert
    Pieper, Karen S.
    Ezekowitz, Justin A.
    Hochman, Judith S.
    Mahaffey, Kenneth W.
    Armstrong, Paul W.
    Granger, Christopher B.
    CRITICAL CARE MEDICINE, 2013, 41 (09) : 2080 - 2087
  • [39] Risk stratification in patients with ST-segment elevation myocardial infarction: The reality in Cuba
    Jimenez, Ailed E. Rodriguez
    Gonzalez, Elibet Chavez
    CORSALUD, 2021, 13 (03): : 260 - 270
  • [40] Factors associated with prehospital delay in patients with ST-segment elevation myocardial infarction
    Kyzer, Matan
    Greener, Gabby Elbaz
    Grosman-Rimon, Liza
    Kusniec, Fabio
    Amir, Offer
    Carasso, Shemy
    CORONARY ARTERY DISEASE, 2022, 33 (04) : 329 - 330